CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory.

Benonisson, Hreinn

CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory. [electronic resource] - Molecular cancer therapeutics 02 2019 - 312-322 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1538-8514

10.1158/1535-7163.MCT-18-0679 doi


Animals
Antibodies, Bispecific--administration & dosage
Antigens, Neoplasm--genetics
CD3 Complex--antagonists & inhibitors
CD4-Positive T-Lymphocytes--drug effects
CD8-Positive T-Lymphocytes--drug effects
Cell Line, Tumor
Female
Humans
Immunologic Memory
Lymphocyte Activation
Melanoma--drug therapy
Mice
Tumor Microenvironment--drug effects
Xenograft Model Antitumor Assays